ROCK Inhibitors in Corneal Diseases and Glaucoma—A Comprehensive Review of These Emerging Drugs

Rho kinase (ROCK) inhibitors have gained significant attention as emerging novel treatment options in the field of ophthalmology in recent years. The evidence supporting their efficacy in glaucoma and corneal pathology includes both in vitro and clinical studies. Among the available options, ripasud...

Descripción completa

Detalles Bibliográficos
Autores principales: Pagano, Luca, Lee, Jason William, Posarelli, Matteo, Giannaccare, Giuseppe, Kaye, Stephen, Borgia, Alfredo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10648286/
https://www.ncbi.nlm.nih.gov/pubmed/37959203
http://dx.doi.org/10.3390/jcm12216736

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10648286/
https://www.ncbi.nlm.nih.gov/pubmed/37959203
http://dx.doi.org/10.3390/jcm12216736

Ejemplares similares